medigraphic.com
SPANISH

Revista de Investigación Clínica

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2007, Number 3

<< Back Next >>

Rev Invest Clin 2007; 59 (3)

Impact on human health of hormonal additives used in animal production

Larrea F, Chirinos M
Full text How to cite this article

Language: Spanish
References: 20
Page: 206-211
PDF size: 59.10 Kb.


Key words:

Hormones, Animal production, Human health.

ABSTRACT

The establishment of the impact of environmental compounds or additives with hormone-like activity on human health still requires further investigation, as well as a reexamination of biologic models and experimental methodology employed so far. In 1988, the FAO/WHO Expert Committee on Food Additives Joint with the Federal Drug Administration (FDA) considered that sexual hormone residues usually present in meat do not represent a risk for human consumption. Nevertheless, this resolution seems to be uncertain since the scientific elements employed for this statement may not be adequate. In this review the principal objections to the evidence used to establish the innocuousness of growth promoter hormones are considered.


REFERENCES

  1. Arneth W. Hormones in animal production –a health risk for the consumer? Z Gesamte Inn Med 1992; 47: 45-7.

  2. Stephany RW. Hormones in meat: different approaches in the EU and in the USA. APMIS Suppl 2001; S357-63; discussion S63-4.

  3. Angsusingha K, Kenny FM, Nankin HR, Taylor FH. Unconjugated estrone, estradiol and FSH and LH in prepubertal and pubertal males and females. J Clin Endocrinol Metab 1974; 39: 63-8.

  4. Rose FJ. Carcinogenicity studies in animals relevant to the use of anabolic agents in animal production. Environ Qual Saf Suppl 1976; 5: 227-37.

  5. McCormick GM, Moon RC. Effect of increasing doses of estrogen and progesterone on mammary carcinogenesis in the rat. Eur J Cancer 1973; 9: 483-6.

  6. Lipsett MB. Factors influencing the rate of metabolism of steroid hormones in man. Ann N Y Acad Sci 1971; 179: 442-9.

  7. Liehr JG, Stancel GM, Chorich LP, Bousfield GR, Ulubelen AA. Hormonal carcinogenesis: separation of estrogenicity from carcinogenicity. Chem Biol Interact 1986; 59: 173-84.

  8. Joint FAO/WHO Expert Committee on Food Additives. Residues of some veterinary drugs in animals and foods. FAO Food Nutr Pap 1988; 41: 1-49.

  9. Le Guevel R, Pakdel F. Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods. Hum Reprod 2001; 16: 1030-6.

  10. Tsai MJ, O’Malley BW. Molecular mechanisms of action of steroid/ thyroid receptor superfamily members. Annu Rev Biochem 1994; 63: 451-86.

  11. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor coactivators and corepressors. Mol Endocrinol 1996; 10: 1167-77.

  12. Spearow JL, Barkley M. Reassessment of models used to test xenobiotics for oestrogenic potency is overdue. Hum Reprod 2001; 16: 1027-9.

  13. Petit F, Le Goff P, Cravedi JP, Valotaire Y, Pakdel F. Two complementary bioassays for screening the estrogenic potency of xenobiotics: recombinant yeast for trout estrogen receptor and trout hepatocyte cultures. J Mol Endocrinol 1997; 19: 321-35.

  14. Littlefield BA, Gurpide E, Markiewicz L, McKinley B, Hochberg RB. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. Endocrinology 1990; 127: 2757-62.

  15. Larrea F, Garcia-Becerra R, Lemus AE, Garcia GA, Perez-Palacios G, Jackson KJ, et al. A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER alpha. Endocrinology 2001; 142: 3791-9.

  16. Jaimez R, Cooney A, Jackson K, Lemus AE, Lemini C, Cardenas M, Garcia R, Silva G, Larrea F. In vivo estrogen bioactivities and in vitro estrogen receptor binding and transcriptional activities of anticoagulant synthetic 17beta-aminoestrogens. J Steroid Biochem Mol Biol 2000; 73: 59-66.

  17. Scientific Committee on Veterinary Measures Relating to Public Health (SCVPH). Assessment of potential risks to human health from hormone residues in bovine meat and meat products. European Commission, 1999. (http://ec.europa.eu/food/ fs/sc/scv/out21_en.html)

  18. US Food and Drug Administration. Guideline 3, part 2: Guideline for toxicological testing. 1999; 1-5.

  19. Joint FAO/WHO Expert Committee on Food Additives. Evaluation of certain veterinary drug residues in food. WHO Technical Report Series 763, World Health Organization, Geneva 1988.

  20. Klein KO, Baron J, Colli MJ, McDonnell DP, Cutler GB, Jr. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 1994; 94: 2475-80.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Invest Clin. 2007;59